Table 1

Baseline characteristics of study subjects

Breathing retraining (n=17)Control (n=16)
Mean (SD) age (years)48.8 (10.9)48.9 (15.6)
Female (%)13 (76.5%)13 (81.3%)
Male (%)4 (23.5%)3 (18.7%)
“Objective” asthma diagnosis16 (94.1%)13 (81.2%)
Mean (SD) Nijmegen score28.82 (6.56)29.13 (8.46)
Mean (SD) AQLQ overall score4.60 (1.01)4.57 (1.27)
Mean (SD) AQLQ symptoms4.68 (1.06)4.60 (1.35)
Mean (SD) AQLQ activities4.57 (1.01)4.56 (1.27)
Mean (SD) AQLQ emotions4.74 (1.41)4.59 (1.73)
Mean (SD) AQLQ environment4.37 (1.21)4.64 (1.34)
Median (range) daily inhaled steroid dosage as μg/beclomethasone equivalent400 (0–2000)800 (0–2000)
Mean rescue bronchodilator inhalers issued in 6 months before randomisation1.4 (1.3)1.7 (3.1)